Common use of Publication and Public Disclosure Clause in Contracts

Publication and Public Disclosure. In accordance with the requirements of this Section 9 (including but not limited to the time-restrictions for “Multi-Center Publications” (Section 9.2), “Confidentiality of Unpublished Data” (Section 9.3)), Institution and Investigator shall have the right to publish or present their Study data following from their own activities conducted under this Agreement. Any proposed publication or presentation shall be consistent with scientific standards by (i) applying the highest industry standards, including but not limited to the Good Publication Practice and the Recommendations for Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors (ICMJE) in their current version and (ii) publishing Study Results first after the primary source publication of the Sponsor is made public. In addition, Institution and Investigator agree to submit any proposed publication or presentation to Sponsor’s Head of Global Medical Publication, email address: for review at least sixty (60) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation. Within sixty (60) days of its receipt, Sponsor shall advise Institution and/or Investigator, as the case may be, in writing of any information contained therein which is Confidential Information (other than Study Results) or which may impair the availability of patent protection for Inventions. Sponsor shall have the right to require Institution and/or Investigator, as applicable, to remove specifically identified Confidential Information (other than Study Results) and/or to delay the proposed publication or presentation for an additional sixty (60) days to enable Sponsor to seek patent protection for Inventions.

Publication and Public Disclosure. In accordance with the requirements of this Section 9 (including but not limited to the time-restrictions for “Multi-Center Publications” (Section 9.2), “Confidentiality of Unpublished Data” (Section 9.3)), Institution and Investigator shall have the right to publish or present their Study data following from their own activities conducted under this Agreement. Any proposed publication or presentation shall be consistent with scientific standards by (i) applying the highest industry standards, including but not limited to the Good Publication Practice and the Recommendations for Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors (ICMJE) in their current version and (ii) publishing Study Results first after the primary source publication of the Sponsor is made public. In addition, Institution and Investigator agree to submit any proposed publication or presentation to Sponsor’s Head of Global Medical Publication, email address: for review at least sixty (60) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation. Within sixty (60) days of its receipt, Sponsor shall advise Institution and/or Investigator, as the case may be, in writing of any information contained therein which is Confidential Information (other than Study Results) or which may impair the availability of patent protection for Inventions. Sponsor shall have the right to require Institution and/or Investigator, as applicable, to remove specifically identified Confidential Information (other than Study Results) and/or to delay the proposed publication or presentation for an additional sixty (60) days to enable Sponsor to seek patent protection for Inventions.

Publication and Public Disclosure. In accordance with the requirements of this Section 9 (including but not limited to the time-restrictions for “Multi-Multi- Center Publications” (Section 9.2), “Confidentiality of Unpublished Data” (Section 9.3)), Institution and Investigator shall have the right to publish or present their Study data following from their own activities conducted under this Agreement. Any proposed publication or presentation shall be consistent with scientific standards by (i) applying the highest industry standards, including but not limited to the Good Publication Practice and the Recommendations for Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors (ICMJE) in their current version and (ii) publishing Study Results first after the primary source publication of the Sponsor is made public. In addition, Institution and Investigator agree to submit any proposed publication or presentation to Sponsor’s Head of Global Medical Publication, email address: for review at least sixty (60) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation. Within sixty (60) days of its receipt, Sponsor shall advise Institution and/or Investigator, as the case may be, in writing of any information contained therein which is Confidential Information (other than Study Results) or which may impair the availability of patent protection for Inventions. Sponsor shall have the right to require Institution and/or Investigator, as applicable, to remove specifically identified Confidential Information (other than Study Results) and/or to delay the proposed publication or presentation for an additional sixty (60) days to enable Sponsor to seek patent protection for Inventions.